Erdtmann Rainer M 4
Research Summary
AI-generated summary
Biomea Fusion (BMEA) Director Erdtmann Receives Award
What Happened Rainer M. Erdtmann — listed as a Director and as the company's President, Chief Operating Officer, Principal Financial Officer, and Principal Accounting Officer — was granted a derivative award on April 1, 2026 covering 452,512 shares. The Form 4 reports the acquisition price as $0.00, indicating this is a stock option/award rather than an open-market purchase or sale.
Key Details
- Transaction date: 2026-04-01; filing date: 2026-04-03 (filed within the normal Form 4 reporting window).
- Grant: 452,512 shares (derivative award); reported acquisition price $0.00 and reported total value $0 on the Form 4 line.
- Shares owned after transaction: not specified in the supplied filing details.
- Footnote: the option vests in 16 substantially equal quarterly installments beginning after April 1, 2026 and will be fully vested and exercisable on April 1, 2030, subject to Erdtmann’s continued service.
- No 10b5-1 plan, tax-withholding sale, or late filing was indicated in the provided data.
Context This was an award of derivative securities (stock options or similar) that will vest over four years; the recipient does not immediately own marketable shares unless and until options are exercised and any vesting conditions are met. Awards like this are common as compensation/retention tools and are different from open-market purchases, which some investors treat as a stronger near-term bullish signal.